Your Article Summary
NPS Reports Three Teduglutide Abstracts Accepted for Presentation at Digestive Disease Week Conference
NPS Pharmaceuticals, 05/29/09
NPS Pharmaceuticals, Inc. reported that three abstracts addressing sub-study data from the company's completed Phase 3 study of GATTEX in patients with short bowel syndrome were accepted for presentation at the 2009 Digestive Disease Week conference. The DDW conference is being held from May through June 2009 at McCormick Place in Chicago, Illinois. The abstract titles and presentation times for two oral presentations and one poster presentation are summarized below.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien plc to Report First-Quarter Results on January 2010
Covidien, 12/17/09
ONC to Explain Community I.T. Project
HealthDataManagement, 12/17/09
MediGene AG presents future business plan at annual analyst conference
MediGene, 12/16/09
Article Search
Sponsor


See Latest Articles


